Fulgent Genetics, INC Form 4 insider transactions

Paul Kim, CFO and Treasurer of Fulgent Genetics, reported the disposal of shares to cover tax obligations arising from vesting restricted stock units.

Gao Hanlin, Chief Scientific Officer of Fulgent Genetics, reports the disposal of shares to cover tax obligations arising from vesting restricted stock units.

Paul Kim, CFO and Treasurer of Fulgent Genetics, Inc., reports the withholding of 669 common stock shares to cover tax obligations arising from vested restricted stock units.

Jian Xie, President and COO of Fulgent Genetics, sold 653 shares of common stock on May 23, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Fulgent Genetics CEO Ming Hsieh reports disposition of shares to cover tax obligations and details beneficial ownership through trusts and custodial accounts.

Gao Hanlin, Chief Scientific Officer of Fulgent Genetics, reports the withholding of 362 common stock shares to cover tax obligations arising from vesting restricted stock units.

Director Michael Nohaile reports acquiring 8,000 shares of Fulgent Genetics common stock on May 16, 2024, through restricted stock units.

Regina Groves, a director at Fulgent Genetics, reported the acquisition of 4,000 shares of common stock and stock options for 5,481 shares on May 16, 2024.

Director Linda Marsh acquired 8,000 shares of Fulgent Genetics common stock on May 16, 2024, as part of a restricted stock unit grant.

Jian Xie, President and COO of Fulgent Genetics, reports the withholding of shares to cover tax obligations and discloses holdings in a family trust.

Paul Kim, CFO and Treasurer of Fulgent Genetics, reports the withholding of 1,412 shares of common stock to cover tax obligations arising from vesting restricted stock units.

Fulgent Genetics CEO Ming Hsieh reports the withholding of shares to cover tax obligations and details beneficial ownership through various trusts and custodial accounts.

Gao Hanlin, Chief Scientific Officer of Fulgent Genetics, reports disposition of shares to cover tax obligations arising from vesting of restricted stock units.

Jian Xie, President and COO of Fulgent Genetics, reports the withholding of shares to cover tax obligations and discloses securities held by The Hsieh Family Dynasty Trust.

CFO and Treasurer of Fulgent Genetics, Paul Kim, reports disposition of shares to cover tax obligations arising from vesting of restricted stock units.

Fulgent Genetics' Chief Scientific Officer, Gao Hanlin, reports the withholding of 1,154 common stock shares to cover tax obligations arising from vesting restricted stock units.

Fulgent Genetics CEO Ming Hsieh, through the Ming Hsieh Trust, terminated a 2022 prepaid variable forward agreement and entered into a new agreement in March 2024, involving 1,000,000 shares of common stock.

Jian Xie, President and COO of Fulgent Genetics, reports the withholding of shares to cover tax obligations and beneficial ownership through a family trust.

Paul Kim, CFO and Treasurer of Fulgent Genetics, reports the disposal of shares to cover tax obligations arising from vesting restricted stock units.

Hanlin Gao, Chief Scientific Officer of Fulgent Genetics, reports the disposal of shares to cover tax obligations arising from vesting restricted stock units.

Hanlin Gao, Chief Scientific Officer of Fulgent Genetics, reports acquisition and disposal of common stock due to vesting of restricted stock units and tax withholding.

Paul Kim, CFO and Treasurer of Fulgent Genetics, reports the acquisition and disposal of company stock, including shares vesting from performance-based restricted stock units and shares withheld for tax obligations.

CEO Ming Hsieh reports acquisition and disposal of Fulgent Genetics stock due to vesting of restricted stock units and tax obligations.

Jian Xie, President and COO of Fulgent Genetics, reports the acquisition and disposal of company stock, including shares vesting from performance-based restricted stock units and shares withheld for tax obligations.

CFO of Fulgent Genetics, Paul Kim, reports the withholding of shares to cover tax obligations related to vesting restricted stock units.

Jian Xie, President and COO of Fulgent Genetics, reports a transaction involving the withholding of shares to cover tax obligations related to vesting restricted stock units.

Gao Hanlin, Chief Scientific Officer of Fulgent Genetics, reports the withholding of shares to cover tax obligations related to vesting restricted stock units.

CEO Ming Hsieh reports disposition of Fulgent Genetics shares to cover tax obligations from vesting restricted stock units.